Previous 10 | Next 10 |
2024-02-19 01:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-29 09:29:24 ET More on CareDx CareDx's Turmoil: Risks Appear Priced In Circling Back On CareDx, Can The Rally Continue CareDx, Inc (CDNA) Q3 2023 Earnings Call Transcript CareDX drops after jury votes in favor of Natera in patent fight (update) ...
CareDx Found to Have Not Infringed on Patent ‘180 CareDx Intends to Seek Judicial Review of Decision and Monetary Damages on Patent ‘544 No Impact to Patient or Physician Access to AlloSure or AlloMap Testing CareDx, Inc. (Nasdaq: CDNA) – The Transpl...
2024-01-26 13:32:36 ET More on CareDx, Natera, etc. CareDx's Turmoil: Risks Appear Priced In Natera: Squeezing The Last Drop From NIPT Growth Engine Circling Back On CareDx, Can The Rally Continue Invitae offloads reproductive health assets to Natera ...
2024-01-17 13:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CareDx Symposium to Highlight New Real-World Use Cases Using its Testing and Digital Solutions for Improved Patient Risk Management CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiat...
2024-01-09 08:39:22 ET More on CareDx CareDx's Turmoil: Risks Appear Priced In Circling Back On CareDx, Can The Rally Continue CareDx stock climbs after Q3 beats, guidance boost For further details see: CareDx sees FY24 revenue $279M-$280M above high end ...
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today reported preliminary financial results for the fourt...
2023-12-28 05:23:01 ET Summary CareDx specializes in solutions for transplant patients, but faces challenges, including legal setbacks and regulatory hurdles. The company won Medicare coverage for its HeartCare Multimodality Service and raised its revenue guidance for 2023. Ho...
2023-12-27 13:00:46 ET Summary CareDx, Inc is a small diagnostic firm that develops and commercializes diagnostic solutions for transplant patients and caregivers. The stock has soared over the past two months thanks to better than expected Q3 results, the overall rally in the mar...
News, Short Squeeze, Breakout and More Instantly...
CareDx Inc. Company Name:
CDNA Stock Symbol:
NASDAQ Market:
2024-06-20 11:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Surveillance Monitoring with Both AlloSure Kidney and the AlloView AI-Enabled Risk Prediction Model Improves the Detection of All Types of Allograft Rejection AlloSure Kidney Detected Subclinical Rejection in Clinically Stable Patients and AlloSure Kidney dd-cfDNA Levels were Elevated Pri...
AI-Derived AlloView Results Correlate with Presence and Type of Biopsy Proven Kidney Rejection Longitudinal Monitoring with AlloSure Kidney Enables Earlier Identification of Graft Injury and Assessment of Rejection Treatment KOAR Data Show Kidney Biopsies Informed by AlloSure Dete...